BioCentury
ARTICLE | Company News

MAXY, ITMN in interferon deal

September 5, 2001 7:00 AM UTC

Maxygen (MAXY) will develop second generation interferon gamma products for InterMune (ITMN), which will take the compounds into clinical development. Payments to MAXY, including upfront license fees,...